相关实验视频

Updated: Jan 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

对于远端中血管阻塞的血栓切除术:最近的试验和新兴策略的教训

¹Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Neurointervention

|October 13, 2025

概括

血管内血栓切除术对远端中血管封闭 (DMVOs) 没有任何好处,与大型血管封闭不同. 最佳的患者选择是急性缺血性中风未来治疗策略的关键.

科学领域:

神经学神经学
干预心脏病学干预心脏病学
血管外科血管外科

背景情况:

随机对照试验 (RCT) 已经评估了急性缺血性中风的内血管血栓切除术.
血栓切除术的有效性已被确立为大血管封闭 (LVOs).
对于远端中血管封闭 (DMVOs) 的临床益处仍然不确定.

研究的目的:

在患有DMVOs的患者中分析血管内血栓切除术的疗效.
确定影响DMVO血栓切除试验结果的因素.
为了指导未来的研究和患者选择DMVO干预措施.

主要方法:

最近的随机对照试验 (RCT) 的综述,包括EndovaSCular Treatment to Improve outcomes for Medium Vessel Occlusions (ESTRO),Endovascular治疗加上最好的医疗治疗 (BMT) 与仅仅针对MedIum VeSsel Occlusion sStroke (EMBRACE) 的 BMT,以及与远端动脉封闭相关的急性缺血性中风中机械血栓切除术的评估 (DISTALS).
对试验群体的分析,重点关注年龄,神经学缺陷和种族代表性.
考虑新兴设备创新和辅助疗法.

主要成果:

最近的RCT没有证明血栓切除对DMVO的临床益处.
试验人群主要包括有轻度神经缺陷的老年患者.
亚洲患者的代表性有限,这是一个具有明显中风概况的人口结构.
在特定的患者亚组中观察到更高的并发症风险.

结论:

目前的证据不支持DMVO的常规内血管血栓切除术.
包括年龄和并发症在内的患者选择标准至关重要.
需要进一步的研究来确定血栓切除术在特定的DMVO患者群体中的作用,考虑到种族差异和内动脉样硬化患病率.

关键词:

临床试验临床试验是指临床试验的临床试验.缺血性中风是因为缺血性中风.进行血栓切除术 (thrombectomy).

更多相关视频

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

相关概念视频

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...